Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Terazosin hydrochloride dihydrate (Heitrin dihydrate) is a selective α1-adrenoceptor antagonist, used for treatment of symptoms of an enlarged prostate (BPH).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | In stock | $ 36.00 | |
100 mg | In stock | $ 57.00 | |
200 mg | In stock | $ 85.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 41.00 |
Description | Terazosin hydrochloride dihydrate (Heitrin dihydrate) is a selective α1-adrenoceptor antagonist, used for treatment of symptoms of an enlarged prostate (BPH). |
In vitro | Terazosin results in a significant loss of cell viability, via induction of apoptosis in a dose-dependent manner in prostate cancer cells. Terazosin suppresses prostate growth potentially via α 1-adrenoceptor-independent actions gains further support from another study documenting that Doxazosin inhibits proliferation of human vascular smooth muscle cells independently of an antagonistic effect on α1-adrenoceptor. [1] Terazosin blocks HERG currents in Xenopus oocytes with IC50 of 113.2 mM, while Terazosin blocks HERG channel inhibition in human HEK 293 cells with IC50 of 17.7 mM. [2] Terazosin or genistein treatment inhibits the growth of DU-145 cells in a dose-dependent manner, whereas has no effect on normal prostate epithelial cells. Terazosin results in the genistein-induced arrest of DU-145 cells in G2/M phase being overridden and an increase in apoptotic cells, as evidenced by procaspase-3 activation and PARP cleavage. [3] Terazosin induces cytotoxicity in PC-3 and human benign prostatic cells with an IC50 of more than 100 mM. [4] |
In vivo | Terazosin significantly inhibits vascular endothelial growth factor induced angiogenesis in nude mice with an IC50 of 7.9 mM, showing that it has a more potent anti-angiogenic than cytotoxic effect. Terazosin also effectively inhibits vascular endothelial growth factor induced proliferation and tube formation in cultured human umbilical vein endothelial cells (IC50 9.9 and 6.8 mM, respectively). [4] |
Synonyms | Flotrin dihydrate, Terazosin HCl Dihydrate, Dysalfa dihydrate, Heitrin dihydrate |
Molecular Weight | 459.92 |
Formula | C19H25N5O4·HCl·2H2O |
CAS No. | 70024-40-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (54.4 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Terazosin hydrochloride dihydrate 70024-40-7 GPCR/G Protein Neuroscience Adrenergic Receptor Inhibitor bladder Beta Receptor inhibit Flotrin dihydrate Flotrin Dihydrate Terazosin HCl pressure α1-adrenoceptor Heitrin Dysalfa Dihydrate Terazosin Hydrochloride Terazosin HCl Dihydrate quinazoline blood Heitrin Dihydrate Dysalfa dihydrate benign Heitrin dihydrate prostatic Dysalfa Flotrin hyperplasia Terazosin hydrochloride Dihydrate high inhibitor